https://doi.org/10.4081/aiua.2022.2.248

The association of bladder cancer and Cannabis: A systematic review

Vol. 94 No. 2 (2022)
Submitted: March 18, 2022
Accepted: April 5, 2022
Published: June 30, 2022
Bladder cancer; Cannabis; Cannabinoids; marijuana; legalization
Abstract Views: 1485
PDF: 1156
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Vahid Mehrnoush
Department of Urology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Stacy Grace de Lima
Inflammation Research Network-Snyder Institute for Chronic Disease, Departments of Physiology and Pharmacology and Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
Ahmed Kotb
drahmedfali@gmail.com
https://orcid.org/0000-0002-1484-1332
Department of Urology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.
Matthew Eric Hyndman
Department of Urology, Southern Alberta Institute of Urology, Calgary, Alberta, Canada.

Objective: To assess the association between Cannabis use and bladder cancer. Methods: A systematic literature review was performed using studies published in electronic databases including PubMed, MEDLINE, and Google Scholar. Due to the scarcity of literature on this topic, the search was not limited to a specific design, year of publication, or human studies. The studies were screened by two reviewers in the following steps; first, the studies were discovered according to the predetermined search strategy; second, the unrelated studies and duplicates were eliminated by screening the abstracts, titles, and keywords; third, the full text of relevant and eligible papers were critically appraised and assessed for the risk of bias using the respective tool. The two review authors independently assessed the risk of bias and outcome levels using the Newcastle-Ottawa Scale for the outcomes in observational studies. Any disagreements were settled by a third party. Results: The search strategy yielded 39 research articles. After removing 21 duplicates, 18 publications were eligible for title and abstract review. Thirteen studies were found to be irrelevant and subsequently excluded. Only three full-text articles were evaluated and included in the qualitative synthesis. Conclusions: The role of Cannabis in bladder cancer has been seldom studied. The small number of studies show contradictory findings; potential carcinogenic versus protective effect. The growing interest in Cannabis use after legalization necessitates further investigations with a robust design to assess the long-term effect of Cannabis on bladder cancer.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Russell C, Rueda S, Room R, et al. Routes of administration for Cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. Int J Drug Policy. 2018; 52:87-96. DOI: https://doi.org/10.1016/j.drugpo.2017.11.008
Felder CC, Dickason-Chesterfield AK, Moore SA. Cannabinoid biology: The search for new therapeutic targets. Mol Interv. 2006;6:149-61. DOI: https://doi.org/10.1124/mi.6.3.6
Skeldon SC, Goldenberg SL. Urological complications of illicit drug use. Nat Rev Urol. 2014; 11:169-77. DOI: https://doi.org/10.1038/nrurol.2014.22
Chacko JA, Heiner JG, Siu W, et al. Association between marijuana use and transitional cell carcinoma. Urology. 2006; 67:100-4. DOI: https://doi.org/10.1016/j.urology.2005.07.005
Thomas AA, Wallner LP, Quinn VP, et al. Association between Cannabis use and the risk of bladder cancer: results from the California Men’s Health Study. Urology. 2015; 85:388-92. DOI: https://doi.org/10.1016/j.urology.2014.08.060
Wells G, O’Connell D, Peterson J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in metaanalysis | Request PDF. 2000; Available from: https://www.researchgate.net/publication/261773681_The_Newcastle-Ottawa_Scale_NOS_for_Assessing_the_Quality_of_Non-Randomized_Studies_in_Meta-Analysis.
Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993; 85:19-24. DOI: https://doi.org/10.1093/jnci/85.1.19
Sidney S, Quesenberry CPJ, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997; 8:722-8. DOI: https://doi.org/10.1023/A:1018427320658
Ramos JA, Bianco FJ. The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. Indian J Urol. 2012; 28:9-14. DOI: https://doi.org/10.4103/0970-1591.94942
Rajanahally S, Raheem O, Rogers M, et al. The relationship between Cannabis and male infertility, sexual health, and neoplasm: a systematic review. Andrology. 2019; 7:139-47. DOI: https://doi.org/10.1111/andr.12585
Nieder AM, Lipke MC, Madjar S. Transitional cell carcinoma associated with marijuana: case report and review of the literature. Urology. 2006; 67:200. DOI: https://doi.org/10.1016/j.urology.2005.08.006
Tyagi V, Philips BJ, Su R, et al. Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol. 2009; 181:1932-8. DOI: https://doi.org/10.1016/j.juro.2008.11.078
Wang Z-Y, Wang P, Bjorling DE. Activation of cannabinoid receptor 2 inhibits experimental cystitis. Am J Physiol Regul Integr Comp Physiol. 2013; 304:R846-53. DOI: https://doi.org/10.1152/ajpregu.00585.2012
Freeman RM, Adekanmi O, Waterfield MR, et al. The effect of Cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17:636-41. DOI: https://doi.org/10.1007/s00192-006-0086-x
Kavia RBC, De Ridder D, Constantinescu CS, et al. Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler. 2010; 16:1349-59. DOI: https://doi.org/10.1177/1352458510378020

How to Cite

Mehrnoush, V. ., de Lima, S. G. ., Kotb, A., & Hyndman, M. E. (2022). The association of bladder cancer and Cannabis: A systematic review. Archivio Italiano Di Urologia E Andrologia, 94(2), 248–251. https://doi.org/10.4081/aiua.2022.2.248

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.